Editorial series
Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors
theheart.org forumExchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Most popular
- ESC issues "practical guide" to new oral anticoagulants in AF
- Dabigatran "real-life" results suggest caution needed
- How low should you go? Experts debate latest salvo in the war on sodium
- Apixaban superior to warfarin across range of INR values, ARISTOTLE analysis
- No benefit of fish oil in high-risk patients
- Long-term PROTECT-AF analysis: Watchman attains efficacy superiority over warfarin in AF
- Hormone therapy associated with MI in male-to-female transsexuals
- Few failures show up in Durata, Riata ST Optim defibrillator-lead analysis
- Low-dose anticoagulation appears safe, effective with new-generation heart valve
- Sliding-scale hydration reduces six-month clinical events in PCI patients
- Why Does the QRS Morphology Change?
- Fish oils to prevent CHD . . . it's now official: A definite "no go"
- Disagreeing with an influential thought leader on ICD use
- What can you conclude from these images?
- How low should you go? Experts debate latest salvo in the war on sodium
- Naturopathy isn't magic. It's conversation and nurturing.
- IOM: No clear benefits to slashing sodium intake to 1500 mg/day
- No benefit of fish oil in high-risk patients
- Hormone therapy associated with MI in male-to-female transsexuals
- Dabigatran "real-life" results suggest caution needed
Test your knowledge
RELEASE DATE: Jan 09, 2013 11:05 AM EST
RELEASE DATE: Feb 12, 2013 10:00 AM EST
RELEASE DATE: Apr 15, 2013 3:50 PM EDT
Trial slides of the month
Overviews of top trials including background, results, and commentaries
- HPS2-THRIVE (Niacin/Laropiprant vs Placebo for Raising HDL Cholesterol)
- PEITHO (Tenectaplase plus Heparin vs Heparin Alone in Pulmonary Embolism)
- CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
- STREAM (Tenectaplase plus Antithrombotic Therapy vs Primary PCI in STEMI)
- TERISA (Ranolazine vs Placebo in Diabetic Patients with Angina)
































